What to know about prostate cancer

Written in association with: Mr Ahmed Ali
Published: | Updated: 24/01/2025
Edited by: Jessica Wise

Prostate cancer is one of the most common cancers in men, and the chances of contracting it increase as men age. In this article, consultant urologist Dr Ahmed Ali explains the signs of prostate cancer and treatment options.

 

 

The prostate is a small gland in the pelvis that produces the fluid which carries the sperm from the testicles during ejaculation.

Prostate cancer is typically diagnosed in men over the age of 65, but the risk increases after the age of 50. It rarely occurs in younger men, but it is possible that a lack of testing and awareness can contribute to underdiagnosis. As it advances in stages, the cancer can begin to spread to other organs and tissues.

 

What are the signs of prostate cancer?

Prostate cancer tends to develop very slowly and may be asymptomatic over many years. In the course of prostate cancer, the prostate enlarges and eventually can become big enough to obstruct the urinary tract, leading to symptoms such as:

  • Increased frequency of urination
  • Difficulty starting urination
  • Painful urination
  • Painful ejaculation, or inability to ejaculate
  • Blood in the urine (haematuria)

 

How is prostate cancer diagnosed?

Often, men who begin to struggle with these symptoms and seek diagnosis will often undergo a blood test as one of the preliminary tests, which will reveal elevated levels of prostate-specific antigen (PSA).

However, an enlarged prostate and the accompanying symptoms are not necessarily indicative of prostate cancer – an enlarged prostate commonly occurs in ageing men due to a hormone called dihydrotestosterone which triggers growth. When the prostate enlarges or becomes inflamed, it begins to produce PSA.

High levels of PSA can be due to benign prostate enlargement (BPE), prostatitis, a urinary tract infection (UTI), ageing, medications like testosterone-replacement therapy, or even just vigorous exercise.

To confirm the diagnosis, further tests such as digital rectal exams (DRE), MRIs, and prostate biopsies may be performed.

 

How is prostate cancer treated?

The prognosis for prostate cancer varies widely depending on the stage at diagnosis and the cancer’s aggressiveness. Localised prostate cancer, which has not spread beyond the prostate, has a very high survival rate. Nearly all men diagnosed with early-stage prostate cancer survive for at least five years, with many living for much longer. However, if the cancer has spread to other parts of the body, the prognosis becomes more challenging.

Management and treatment of prostate cancer depend on the stage and grade of the cancer, as well as the patient’s overall health. Options include:

  • Active surveillance for low-risk cases
  • Surgical removal of the prostate (prostatectomy)
  • Radiation therapy
  • Chemotherapy
  • High-intensity focal ultrasound (HIFU), which utilizes heat to kill the cancer cells without affecting normal cells and has less side effect than radical treatments
  • Cryotherapy, which is performed by liquid nitrogen being injected into the prostate to destroy the cancer cells

In recent years, newer treatments like immunotherapy and targeted therapies have also emerged, offering hope for better outcomes with fewer side effects. Understanding these aspects of prostate cancer can help guide discussions with healthcare providers and inform decisions about screening and treatment. It is highly recommended that men undergo regular screening in order to catch prostate cancer in its earliest stages.

 

If you have concerns regarding your prostate, consult with Dr Ali via his Top Doctors profile.

By Mr Ahmed Ali
Urology

Mr Ahmed Ali is a highly experienced consultant urological surgeon who specialises in bladder cancerprostate cancerbenign prostatic enlargementkidney stonestesticular cancer, as well as urinary tract infections, amongst many other urological-related conditions.

He currently practises at the highly prestigious The London Clinic hospital where he consults patients from both overseas and the UK. He also practices in Surrey at The Parkside Suite (Frimley Park Hospital), and the Circle Mount Alvernia Hospital in Guildford. He also recently joined the men’s health team at OneWelbeck in London, a clinic that provides a holistic approach to men’s health including prostatebladder, and andrology health check using cutting edge technology. He is the current lead for bladder cancer services at the Frimley Health NHS Foundation Trust’s urology department, the founder of the Arab British Urological Society, as well as being a consultant urologist at Urology Partners LLP.

He is an expert when it comes to urological oncology, and is highly qualified in relation to every aspect of urological-related diseases. He qualified as a doctor in 2005 after successfully completing an MBChB in medicine at the distinguished University of Baghdad. He moved to the UK and started training as a junior doctor in 2007, which allowed him to go on to obtain a master's degree in urology in 2013 from the University College London.

Ahmed started his urological training at St James Hospital in Leeds and subsequently undertook a fellowship at Addenbrooke’s Hospital in Cambridge. During his fellowship, he studied the role of MRI in the diagnosis of prostate cancer which is now the main method of prostate cancer diagnosis. Furthermore, he completed 5 years of higher urological training at the Kent, Surrey and Sussex Deanery by completing the FRSC Urol exam in 2017.

Upon his appointment as a consultant at the outstanding Frimley Health NHS Foundation Trust in October 2017, Mr Ali was responsible for managing the bladder cancer services in the trust. In the past 5 years, Mr Ali has impressively introduced multiple new cutting-edge technologies in the management of bladder cancer. He introduced the use of radiofrequency-induced hyperthermia treatment for high-risk non-muscle invasive bladder cancer, and the use of laser in removing bladder cancer lesions with minimal blood loss. In addition, he regularly trains more junior urologists in using modern technologies in the diagnosis and treatment of bladder cancer.

After the COVID pandemic, Mr Ali started a new mobile service to help other Trusts in the UK deal with their long wait in treating urological cancers. He regularly undertakes and trains doctors in prostate diagnostic procedures. He follows the pathway of using MRI scan, followed by biopsies, using the fusion method to accurately diagnose prostate cancer using the precision point technique. This ensures accurate diagnosis of the type and grade of prostate cancer with minimal side effects, such as infection and pain.

With regard to education, Mr Ali is the consultant lead for simulation education at Frimley Health NHS Foundation Trust. He has been involved in multiple successful programmes at the trust which involve simulation training. He also is a chief investigator in an NIHR study looking for a biomarker for the treatment of overactive bladder syndrome. 

View Profile

Overall assessment of their patients


  • Related procedures
  • Sexually transmitted infections (STIs)
    Vaginoplasty
    Penis Enlargement (Phalloplasty)
    Adult circumcision
    Laparoscopy
    Urologic Oncology
    Geriatric Urology
    Kidney transplantation
    Phimosis
    Short frenulum
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.